The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

oculis.com

Founded Year

2017

Stage

Series C | Alive

Total Raised

$93.42M

Last Raised

$57M | 1 yr ago

About Oculis

Oculis is a Lausanne, Switzerland-based clinical-stage biopharmaceutical company developing topical ophthalmic treatments for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and lives of patients worldwide.

Oculis Headquarter Location

EPFL Innovation Park Building D

Lausanne, 1015,

Switzerland

+41 21 711 3970

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Oculis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Oculis is included in 2 Expert Collections, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

D

Diabetes

1,750 items

Oculis Patents

Oculis has filed 6 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Pharmaceutical industry
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/29/2017

10/5/2021

Drug delivery devices, Dosage forms, Pharmacokinetics, Diseases of the eye and adnexa, Ophthalmology

Grant

Application Date

11/29/2017

Grant Date

10/5/2021

Title

Related Topics

Drug delivery devices, Dosage forms, Pharmacokinetics, Diseases of the eye and adnexa, Ophthalmology

Status

Grant

Oculis Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Oculis Rank

  • When was Oculis founded?

    Oculis was founded in 2017.

  • Where is Oculis's headquarters?

    Oculis's headquarters is located at EPFL Innovation Park, Lausanne.

  • What is Oculis's latest funding round?

    Oculis's latest funding round is Series C.

  • How much did Oculis raise?

    Oculis raised a total of $93.42M.

  • Who are the investors of Oculis?

    Investors of Oculis include Brunnur Ventures, Silfurberg, Pivotal bioVenture Partners, Novartis Venture Funds, Bay City Capital and 11 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.